Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

Subjects:

Proteasomal activity decreases with ApoE4 expression. by Nathan R. Zuniga (20422428)

Autophagic flux decreased in an age-dependent manner in the heart. by Julian M. Carosi (9407082)

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

“…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”

MigC interacts with and decreases the activity of MurD. by Jeanette M. Critchlow (21553796)

Splenocytes from Tcj2 mRNA LNP—Immunized mice decrease <i>T</i>. <i>cruzi</i> infection <i>in vitro</i>. by Leroy Versteeg (4248760)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…Both NCS-1 and NLGN-3 are crucial for neuronal development, synapse formation, and neuron activity, and their reduction is associated with decreased synapse strength. …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…Both NCS-1 and NLGN-3 are crucial for neuronal development, synapse formation, and neuron activity, and their reduction is associated with decreased synapse strength. …”

Key characteristics of non-healed DU wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Overall characteristics of wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

FDA-approved reference marker and capturing wound image. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Average days to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of the Non-healed but Improved PIs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Comparison of mean days of wound healing across different wound types for wounds healed in more than 3 months durations (2022 and 2023). by Heba Tallah Mohammed (2822432)

Subjects:

Key characteristics of non-healed PI at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects: